Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: MPER-Peptide Liposome Immunogen Testing |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2014-11-21 |
| Study Made Public: | 2016-06-01 |
Title
Neutralization of sera derived from NHP Studies 204 and 205 (MPER-liposomes)
Description
CAVD 470 is an immunogenicity study to evaluate neutralization activity following peptide liposome and adjuvant regimens in NHP Studies 204 and 205.
Sign in to see full information about this study and to download study data.
Products
GLA Alum Alum/GLA MPER 656 GTH1 peptide liposomeIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.